학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 326건 | 목록 30~40
Periodical
Methods of Information in Medicine; May 2002, Vol. 41 Issue: 5 p414-418, 5p
Academic Journal
Studies in Health Technology & Informatics; 2013, Vol. 190, p13-17, 5p, 1 Diagram, 3 Graphs
Academic Journal
Eleftheriadou I; Diabetes Center, First Department of Propaedeutic Internal Medicine, Medical School, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.; Didangelos T; Diabetes Center, First Department of Internal Medicine, Medical School, AHEPA Hospital, Aristotle University, Thessaloniki, Greece.; Pappas AC; Diabetic Center, Venizelion Hospital, Iraklion, Greece.; Anastasiou E; Endocrinology Clinic, Alexandra General Hospital, Athens, Greece.; Vasilopoulos C; Endocrinology Department, Evangelismos General Hospital of Athens, Athens, Greece.; Zoupas C; Diabetes Center, Hygeia Hospital, Athens, Greece.; Manes C; Second Department of Internal Medicine, Papageorgiou General Hospital, Thessaloniki, Greece.; Tsatsoulis A; Endocrinology Department, Ioannina University Hospital, Ioannina, Greece.; Benroubi M; Diabetes Center, Polycliniki General Hospital, Athens, Greece.; Pangalos E; Diabetes Department, Thermi Hospital, Thessaloniki, Greece.; Thomakos P; Diabetes Center, Hygeia Hospital, Athens, Greece.; Gerasimidi-Vazeou A; Diabetes Center, Panagiotis and Aglaia Kyriakou Children's General Hospital, Athens, Greece.; Tentolouris N; Diabetes Center, First Department of Propaedeutic Internal Medicine, Medical School, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece. ntentol@med.uoa.gr.
Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101142469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2520-8721 (Electronic) Linking ISSN: 11093099 NLM ISO Abbreviation: Hormones (Athens) Subsets: MEDLINE
Academic Journal
Dhindsa RS; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, US. ryan.dhindsa@astrazeneca.com.; Burren OS; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Sun BB; Translational Sciences, Research & Development, Biogen Inc., Cambridge, MA, US.; Prins BP; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Matelska D; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Wheeler E; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Mitchell J; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Oerton E; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Hristova VA; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, US.; Smith KR; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Carss K; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Wasilewski S; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Harper AR; Clinical Development, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Paul DS; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Fabre MA; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Runz H; Translational Sciences, Research & Development, Biogen Inc., Cambridge, MA, US.; Viollet C; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Challis B; Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Vitsios D; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Ashley EA; Division of Cardiology, Department of Medicine, Stanford University, Palo Alto, CA, USA.; Whelan CD; Translational Sciences, Research & Development, Biogen Inc., Cambridge, MA, US.; Pangalos MN; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Wang Q; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, US.; Petrovski S; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. slav.petrovski@astrazeneca.com.; Department of Medicine, Austin Health, University of Melbourne, Melbourne, Victoria, Australia. slav.petrovski@astrazeneca.com.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Academic Journal
Durán CO; Digital Health Research and Development, AstraZeneca PLC, Cambridge, UK. Cristina.Duran@astrazeneca.com.; Bonam M; Digital Health Research and Development, AstraZeneca PLC, Cambridge, UK.; Björk E; Cardiovascular, Renal and Metabolism Biopharmaceuticals R&D, AstraZeneca PLC, Gothenburg, UK.; Hughes R; Research and Early Development, Respiratory and Immunology, AstraZeneca PLC, Cambridge, UK.; Ghiorghiu S; Oncology, AstraZeneca PLC, Cambridge, UK.; Massacesi C; Research and Development, AstraZeneca PLC, Gaithersburg, MD, US.; Campbell A; Digital Health Oncology Research and Development, AstraZeneca PLC, San Francisco, CA, USA.; Hutchison E; Emmette Hutchison LLC, Naples, FL, USA.; Pangalos MN; Biophamaceuticals Research and Development, AstraZeneca PLC, Cambridge, UK.; Galbraith S; Oncology Research and Development, AstraZeneca PLC, Gaithersburg, MD, USA.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Bestas B; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Wimberger S; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Department of Chemistry & Molecular Biology, University of Gothenburg, Gothenburg, Sweden.; Degtev D; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Madsen A; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Rottner AK; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Karlsson F; Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Cambridge, UK.; Naumenko S; Department of Biostatistics, Harvard Chan School of Public Health, Boston, MA, USA.; Callahan M; Translational Genomics, Translational Medicine, R&D Oncology, AstraZeneca, Waltham, MA, USA.; Touza JL; Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Francescatto M; Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Cambridge, UK.; Möller CI; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Badertscher L; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Li S; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Cerboni S; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Selfjord N; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Ericson E; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Gordon E; Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Firth M; Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Cambridge, UK.; Chylinski K; Vienna Biocenter Core Facilities, Vienna Biocenter (VBC), Vienna, Austria.; Taheri-Ghahfarokhi A; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Bohlooly-Y M; Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Snowden M; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Pangalos M; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Nuttall B; Translational Genomics, Translational Medicine, R&D Oncology, AstraZeneca, Waltham, MA, USA.; Akcakaya P; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden.; Sienski G; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden. grzegorz.sienski@astrazeneca.com.; Maresca M; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden. marcello.maresca@astrazeneca.com.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
IEEE Transactions on Automatic Control IEEE Trans. Automat. Contr. Automatic Control, IEEE Transactions on. 69(9):6169-6175 Sep, 2024
Academic Journal
Konialis C; InterGenetics, Diagnostic Genetics Center, Athens, Greece.; Spengos K; 1st Department of Neurology, Eginition Hospital, University of Athens School of Medicine, Athens, Greece.; Iliopoulos P; InterGenetics, Diagnostic Genetics Center, Athens, Greece.; Karapanou S; InterGenetics, Diagnostic Genetics Center, Athens, Greece.; Gialafos E; 1st Department of Neurology, Eginition Hospital, University of Athens School of Medicine, Athens, Greece.; Hagnefelt B; InterGenetics, Diagnostic Genetics Center, Athens, Greece.; Vemmos K; Department of Clinical Therapeutics, University of Athens, 'Alexandra' University Hospital, Athens, Greece.; Zakopoulos N; Department of Clinical Therapeutics, University of Athens, 'Alexandra' University Hospital, Athens, Greece.; Pangalos C; InterGenetics, Diagnostic Genetics Center, Athens, Greece.
Publisher: The University Country of Publication: Poland NLM ID: 101138582 Publication Model: Print Cited Medium: Print ISSN: 1899-5276 (Print) Linking ISSN: 18995276 NLM ISO Abbreviation: Adv Clin Exp Med Subsets: MEDLINE
Academic Journal
Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK; National Institute for Health and Care Research, Oxford Biomedical Research Centre, Oxford, UK.; Kelly EJ; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Seegobin S; Biometrics, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Dargan PI; Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, UK; Faculty of Life Sciences and Medicine, King's College London, London, UK.; Payne R; Department of Infection, Immunity and Cardiovascular Disease, The Medical School, University of Sheffield, Sheffield, UK; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Libri V; National Institute for Health and Care Research, University College London Hospitals, Clinical Research Facility, London, UK; National Institute for Health and Care Research, University College London Hospitals, Biomedical Research Centre, London, UK.; Adam M; Clinical Infection Research Group-Edinburgh, Regional Infectious Diseases Unit, NHS Lothian, Edinburgh, UK.; Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; National Institute for Health and Care Research, Oxford Biomedical Research Centre, Oxford, UK.; Martinez-Alier N; Formerly Paediatric Infectious Diseases and Immunology, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK; IQVIA, London, UK.; Church A; Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA.; Jepson B; Biometrics, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Khan M; Clinical Development, BioPharmaceuticals R&D, AstraZeneca, Mississauga, ON, Canada.; Matthews S; Biometrics, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Townsend GT; Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Vekemans J; Formerly Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; National Institute for Health and Care Research, Oxford Biomedical Research Centre, Oxford, UK.; Swanson PA 2nd; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Lambe T; Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, UK; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.; Pangalos MN; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Villafana T; Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; National Institute for Health and Care Research, Oxford Biomedical Research Centre, Oxford, UK.; Green JA; Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. Electronic address: justin.green@astrazeneca.com.
Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Pangalos, E.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어